MRI‐Derived Atrial Substrate Score Predicts Recurrence After First‐Time Cryoballoon Pulmonary Vein Isolation
Pacing and Clinical Electrophysiology · 2026-11-20
DOI: 10.1111/pace.70493 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2026-11-20. Written by Buelent Koektuerk and 7 co-authors. 33 references.
Abstract (original language)
Background and aims The conventional classification of atrial fibrillation (AF) as paroxysmal or persistent may not reflect structural atrial remodeling and has limited value for predicting recurrence after pulmonary vein isolation (PVI). We investigated whether an MRI‐derived substrate score combining left atrial (LA) fibrosis and size improves recurrence risk stratification after first‐time cryoballoon PVI.
Methods
We retrospectively analyzed 69 patients undergoing first cryoballoon PVI; 67 underwent pre‐procedural 3‐Tesla late gadolinium enhancement MRI. LA fibrosis was graded using the UTAH classification; the maximal horizontal LA diameter in the two‐chamber view was measured, and LA volume was calculated with a 3D tool. An exploratory point‐based score was constructed from LA diameter categories (< 44 mm, 0 points; 44–< 48 mm, 2 points; ≥ 48 mm, 4 points) and advanced fibrosis (UTAH stage 3–4, 1 point). Discrimination for 12‐month arrhythmia recurrence was assessed by ROC analysis.
Results
Advanced fibrosis was present in half of the patients with paroxysmal AF, with a similar UTAH distribution in both phenotypes ( p = 0.83). LA diameter and volume were larger in patients with recurrence and discriminated recurrence (AUC 0.95 and 0.92). The substrate score predicted recurrence (AUC 0.96, 95% CI 0.91–0.99), with recurrence rates of 0%, 41% and 96% in low‐, intermediate‐ and high‐risk patients. LA size was the main contributor, with fibrosis providing complementary information, whereas AF phenotype did not provide incremental predictive value.
Conclusions
An MRI‐derived substrate score, with LA size as the main contributor and fibrosis as a complementary marker, predicted arrhythmia recurrence after cryoballoon PVI better than the conventional AF phenotype. External validation is required before clinical implementation.
Cite
APA
Koektuerk, B., Glaenzer, L., Yorgun, H., Aytemir, K., Stöckigt, F., Seyfarth, M., Horlitz, M., & Bansmann, M. (2026). MRI‐Derived Atrial Substrate Score Predicts Recurrence After First‐Time Cryoballoon Pulmonary Vein Isolation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70493
Vancouver
Koektuerk B, Glaenzer L, Yorgun H, Aytemir K, Stöckigt F, Seyfarth M, et al. MRI‐Derived Atrial Substrate Score Predicts Recurrence After First‐Time Cryoballoon Pulmonary Vein Isolation. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70493
BibTeX
@article{Koektuerk2026,
author = {Koektuerk, Buelent and Glaenzer, Lea and Yorgun, Hikmet and Aytemir, Kudret and Stöckigt, Florian and Seyfarth, Melchior and Horlitz, Marc and Bansmann, Martin},
title = {MRI‐Derived Atrial Substrate Score Predicts Recurrence After First‐Time Cryoballoon Pulmonary Vein Isolation},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70493}
}
EUVIMED